Ibrutinib attenuated DSS-induced ulcerative colitis, oxidative stress, and inflammatory cascade by modulating PI3K/Akt and JNK/NFκB pathways

• Liangliang Hao,
• Lina Tariq Alkry,
• Abdullah Alattar,
• Muhammad Faheem,
• Reem Alshaman,
• Fawad Ali Shah,
• Shupeng Li

Affiliations

Liangliang Hao

Hospital of Chengdu University of Traditional Chinese Medicine, China

Lina Tariq Alkry

College of Natural and Health Sciences, Zayed University, Abu Dhabi, United Arab Emirates

Abdullah Alattar

Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

Muhammad Faheem

Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan

Reem Alshaman

Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Tabuk, Tabuk, Saudi Arabia

Fawad Ali Shah

Riphah Institute of Pharmaceutical Sciences, Riphah International University, Islamabad, Pakistan

Shupeng Li

State Key Laboratory of Oncogenomics, School of Chemical Biology and Biotechnology, Shenzhen Graduate School, Peking University, Shenzhen, China